Literature DB >> 35882753

Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.

Hirotaka Hasegawa1, Masahiro Shin2,3, Ryoko Niwa2, Satoshi Koizumi2, Shoko Yoshimoto2, Naoyuki Shono2, Yuki Shinya2, Hirokazu Takami2, Shota Tanaka2, Motoyuki Umekawa2, Shiori Amemiya4, Taichi Kin2, Nobuhito Saito2.   

Abstract

PURPOSE: Pre-surgical diagnosis of skull base chondrosarcoma (SBC) is often challenging due to the resemblance to chordoma. The goal of this study was to develop an optimal method for predicting SBC diagnosis.
METHODS: This retrospective study included patients with histologically diagnosed SBC and skull base chordoma. Their clinical and radiologic features were compared, and the predictive factors of SBC were examined.
RESULTS: Forty-one patients with SBC and 41 with chordoma were included. Most SBCs exhibited hypointensity (25, 64.1%) or isointensity (12, 30.8%) on T1-weighted images, and hyperintensity (34, 87.1%) or mixed intensity (5, 12.8%) on T2-weighted images. MRI contrast enhancement was usually avid or fair (89.7%) with "arabesque"-like pattern (41.0%). The lateral/paramidline location was more common in SBC than in chordoma (85.4% vs. 9.8%; P < 0.01), while midline SBCs (14.6%) were also possible. Multivariate analysis demonstrated that higher apparent diffusion coefficient (ADC) value (unit odds ratio 1.01; 95% confidence interval 1.00-1.02; P < 0.01) was associated with an SBC diagnosis. An ADC value of ≥ 1750 × 10-6 mm2/s demonstrated a strong association with an SBC diagnosis (odds ratio 5.89 × 102; 95% confidence interval 51.0-6.80 × 103; P < 0.01) and yielded a sensitivity of 93.9%, specificity of 97.4%, positive predictive value of 96.9%, and negative predictive value of 95.0%.
CONCLUSION: The ADC-based method is helpful in distinguishing SBC from chordoma and readily applicable in clinical practice. The prediction accuracy increases when other characteristics of SBC, such as non-midline location and arabesque-like enhancement, are considered together.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apparent diffusion coefficient; Chondrosarcoma; Chordoma; Differential diagnosis; Magnetic resonance imaging; Radiologic features; Skull base

Mesh:

Year:  2022        PMID: 35882753     DOI: 10.1007/s11060-022-04097-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  23 in total

1.  MRI of intracranial chordomas. Extent of tumour and contrast enhancement: criteria for differential diagnosis.

Authors:  V Doucet; P Peretti-Viton; D Figarella-Branger; L Manera; G Salamon
Journal:  Neuroradiology       Date:  1997-08       Impact factor: 2.804

2.  Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?

Authors:  Uta Müller; Rahel A Kubik-Huch; Carmen Ares; Eugen B Hug; Roland Löw; Antonios Valavanis; Frank J Ahlhelm
Journal:  Acta Radiol       Date:  2015-02-25       Impact factor: 1.990

3.  Case 139: nasal septum low-grade chondrosarcoma.

Authors:  Amal N Dass; Wilfred C G Peh; Tony W H Shek; Wai Kuen Ho
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105

4.  Chordoma: 18F-FDG PET/CT and MRI imaging features.

Authors:  Joshua T Olson; Doris E Wenger; Peter S Rose; Ivy A Petersen; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2021-02-01       Impact factor: 2.199

Review 5.  Skull base chondrosarcoma.

Authors:  Mohammed Awad; Andrew James Gogos; Andrew H Kaye
Journal:  J Clin Neurosci       Date:  2015-12-24       Impact factor: 1.961

6.  Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa).

Authors:  Stefanie Ehrbar; Rosalind Perrin; Marta Peroni; Kinga Bernatowicz; Thomas Parkel; Izabela Pytko; Stephan Klöck; Matthias Guckenberger; Stephanie Tanadini-Lang; Damien Charles Weber; Antony Lomax
Journal:  Radiother Oncol       Date:  2016-11-04       Impact factor: 6.280

7.  Chondrosarcoma of the nasal septum: skull base imaging and clinicopathologic correlation.

Authors:  C H Rassekh; D W Nuss; S B Kapadia; H D Curtin; J L Weissman; I P Janecka
Journal:  Otolaryngol Head Neck Surg       Date:  1996-07       Impact factor: 3.497

8.  Radiomic analysis of multiparametric magnetic resonance imaging for differentiating skull base chordoma and chondrosarcoma.

Authors:  Longfei Li; Ke Wang; Xiujian Ma; Zhenyu Liu; Shuo Wang; Jiang Du; Kaibing Tian; Xuezhi Zhou; Wei Wei; Kai Sun; Yusong Lin; Zhen Wu; Jie Tian
Journal:  Eur J Radiol       Date:  2019-07-05       Impact factor: 3.528

9.  Chondrosarcomas of the skull base: MR imaging features.

Authors:  S P Meyers; W L Hirsch; H D Curtin; L Barnes; L N Sekhar; C Sen
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

10.  Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.

Authors:  Leif-Erik Bohman; Matthew Koch; Robert L Bailey; Michelle Alonso-Basanta; John Y K Lee
Journal:  World Neurosurg       Date:  2014-07-05       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.